Many platforms used by investigators were never designed with clinical trials in mind. The consequence is a widening infrastructure gap that leaves independent investigators operating complicated ...

Bruce D. Levy, MD, will become executive vice chancellor for medical affairs and dean of Washington University School of ...

Theoretical approaches, treatment preferences, and clinician bias all play a role in the ways we understand eating disorders.

A major health study will put The Ohio State University in the spotlight worldwide. The National Institutes of Health awarded ...

The finding suggests other chemo drugs, too, may be making cancer cells cause a surprising immune-system reaction.

Astellas Pharma has ended a six-year-old collaboration with CytomX Therapeutics designed to both expand the pharma giant’s pipeline of next-gen immuno-oncology treatments and generate up to $1.68 ...

Galectin Therapeutics Inc. (NASDAQ:GALT), the leading developer of galectin-3-targeted therapeutics for patients with MASH cirrhosis and portal hypertension, today announced it has appointed Henry ...

A new discovery from researchers at The University of Texas at Austin and The University of Texas MD Anderson Cancer Center helps explain why some ...

Advent Therapeutics is developing vitamin A therapies aimed at preventing chronic lung disease in premature babies.

Extended long-term survival observed after an additional year of follow-up in ongoing phase 2a clinical trial, with 50% of 46 patients with ...

Galectin Therapeutics Inc. (NASDAQ:GALT), the leading developer of galectin-3-targeted therapeutics for patients with MASH cirrhosis and portal hypertension ...